UK Markets close in 7 hrs 3 mins

Green Cross Corporation (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
373,000.00+7,500.00 (+2.05%)
At close: 3:30PM KST
Full screen
Previous close365,500.00
Open371,500.00
Bid374,500.00 x 0
Ask375,000.00 x 0
Day's range371,000.00 - 389,500.00
52-week range139,500.00 - 538,000.00
Volume229,807
Avg. volume260,460
Market cap4.257T
Beta (5Y monthly)0.92
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date28 Jul 2021 - 02 Aug 2021
Forward dividend & yield1,500.00 (0.42%)
Ex-dividend date29 Dec 2020
1y target est183,455.00
  • US FDA Accepts GC Pharma’s Biologics License Application for Immune Globulin 'GC5107'
    Business Wire

    US FDA Accepts GC Pharma’s Biologics License Application for Immune Globulin 'GC5107'

    GC Pharma (006280.KS) today announced that the United States Food and Drug Administration (FDA) accepted the company’s Biologics License Application (BLA) for 'GC5107 (Immune Globulin Intravenous (Human),10% Liquid)’ intended for the treatment of Primary Humoral Immunodeficiency (PI), a class of inherited genetic disorders that causes an individual to have a deficient or absent immune system.

  • GC Pharma Reports Q1 2021 Results
    Business Wire

    GC Pharma Reports Q1 2021 Results

    GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 31 March 2021.

  • GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’
    Business Wire

    GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’

    GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, participates in a campaign to celebrate World Hemophilia Day.